Citation:Bradley J., Graham M., Suzanne S., Byhardt R., Govindan R., Fowler J. et al, 2005

From Cancer Guidelines Wiki

Citation


Bradley J, Graham M, Suzanne S, Byhardt R, Govindan R, Fowler J et al,. Phase I results of RTOG 0117: A phase I/II dose intensification study using 3DCRT and concurrent chemotherapy for patients with inoperable non-small cell lung cancer. J Clin Oncol 2005;23: 16S, 7063 Available from: http://www.ncbi.nlm.nih.gov/pubmed/20368547.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What is the role of chemotherapy when added to radiotherapy in the treatment of inoperable stage I NSCLC?Associate Professor Christos Karapetiscompleted
What is the role of chemotherapy when added to radiotherapy in the treatment of inoperable stage I NSCLC?Associate Professor Christos Karapetiscompleted
What is the best practice radiotherapy approach in patients with stage I inoperable NSCLC?Professor David Ball MB BS, MD, FRANCZRcompleted
What is the best practice radiotherapy approach in patients with stage II inoperable NSCLC?Professor David Ball MB BS, MD, FRANCZRcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the role of chemotherapy when added to radiotherapy in the treatment of inoperable stage I NSCLC?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the role of chemotherapy when added to radiotherapy in the treatment of inoperable stage I NSCLC?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the role of chemotherapy when added to radiotherapy in the treatment of inoperable stage I NSCLC?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the role of chemotherapy when added to radiotherapy in the treatment of inoperable stage I NSCLC?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the best practice radiotherapy approach in patients with stage I inoperable NSCLC?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the best practice radiotherapy approach in patients with stage I inoperable NSCLC?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the best practice radiotherapy approach in patients with stage II inoperable NSCLC?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the best practice radiotherapy approach in patients with stage II inoperable NSCLC?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What is the optimal radiation dose and fractionation schedule for good performance status patients with inoperable stage III NSCLC undergoing curative therapy?